Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-03-09Clinical Trial Update: Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers [Phase 1]
Phase 1 trial assessing cabiralizumab with nivolumab in selected advanced cancers has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-03-09Clinical Trial Update: Clinical Study of VG161 in Combination With Nivolumab in Subjects With Advanced Pancreatic Cancer [Phase 1, Phase 2]
Clinical study of VG161 in combination with nivolumab in advanced pancreatic cancer across Phase 1 and Phase 2 stages.
-
CLINICAL_TRIALS trial_result · 2022-03-09Clinical Trial Update: Electroporation Potentiated Immunotherapy in Cancer [Phase 2]
Phase 2 trial update evaluating electroporation-potentiated immunotherapy in metastatic pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2022-03-08Clinical Trial Update: Gemcitabine/Capecitabine Followed by SBRT in Pancreatic Adenocarcinoma [Phase 2]
Phase 2 trial evaluating gemcitabine/capecitabine followed by SBRT in pancreatic cancer has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-03-02Clinical Trial Update: S-1 and and Gemcitabine vs Gemcitabine Alone as Adjuvant Chemotherapy for Patients With Resected Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating S-1 plus gemcitabine versus gemcitabine alone as adjuvant therapy after pancreatic cancer resection.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-02-25Clinical Trial Update: A Phase II Clinical Trial of Fruquintinib as Third Line Treatment in Advanced Pancreatic Cancer [Phase 2]
Phase II trial investigating Fruquintinib as third-line treatment for advanced pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2022-02-15Clinical Trial Update: High-dose Vitamin D3 in Pancreas Cancer [Phase 3]
Phase 3 trial of high-dose Vitamin D3 in pancreas cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2022-02-01Clinical Trial Update: Predictors of Tumor Response and of Radiation Therapy Side Effects in Patients With Gastrointestinal Cancers
Clinical trial investigating predictors of tumor response and radiation therapy side effects in gastrointestinal cancers; terminated with po…
-
CLINICAL_TRIALS trial_result · 2022-01-26Clinical Trial Update: A Study of Avelumab, Binimetinib and Talazoparib in Patients With Locally Advanced or Metastatic RAS-mutant Solid Tumors [Phase 1, Phase 2]
Phase 1/2 study of avelumab, binimetinib, and talazoparib in locally advanced or metastatic RAS-mutant solid tumors was terminated; results …
-
CLINICAL_TRIALS trial_result · 2022-01-14Clinical Trial Update: The First Line Treatment of Fruquintinib Combined With Albumin Paclitaxel and Gemcitabine in Pancreatic Cancer Patients [Phase 2]
A Phase 2 clinical trial update evaluating first-line treatment with fruquintinib plus albumin paclitaxel and gemcitabine in pancreatic canc…
-
CLINICAL_TRIALS trial_result · 2022-01-12Clinical Trial Update: Single Patient Protocol for an NRG1 Fusion Positive Metastatic Pancreatic Cancer Patient Using Seribantumab [Phase 2]
Phase 2 single-patient protocol trial update for seribantumab in an NRG1 fusion-positive metastatic pancreatic cancer patient; study complet…
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: A Study of Nab-Paclitaxel and Gemcitabine With or Without Olaratumab (LY3012207) in Participants With Metastatic Pancreatic Cancer [Phase 1, Phase 2]
A combined Phase 1/2 trial evaluated nab-paclitaxel and gemcitabine with or without the angiogenesis-targeting antibody olaratumab in metast…
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: SHR6390 Plus Nab-paclitaxel and Gemcitabine in Advanced/Metastatic Pancreatic Cancer [Phase 2]
Phase 2 trial of SHR6390 with nab-paclitaxel and gemcitabine in advanced/metastatic pancreatic cancer is underway with unknown status.
-
CLINICAL_TRIALS research · 2022-01-11Clinical Trial Update: EL CENTRO: Engaging Latinos in the Center of Cancer Treatment Options [NA]
Clinical trial update for EL CENTRO, focusing on engaging Latinos in cancer treatment decisions; trial status completed with posted results …
-
CLINICAL_TRIALS trial_result · 2021-12-29Clinical Trial Update: Neoadjuvant Stereotactic Body Radiation Therapy for Resectable Adenocarcinoma of the Pancreatic Head and/or Body [NA]
Clinical trial update on neoadjuvant stereotactic body radiation therapy for resectable pancreatic head/body adenocarcinoma; study completed…
-
CLINICAL_TRIALS trial_result · 2021-12-16Clinical Trial Update: A Clinical Trial of Entinostat in Combination With Nivolumab for Patients With Previously Treated Unresectable or Metastatic Cholangiocarcinoma and Pancreatic Adenocarcinoma [Phase 2]
A Phase 2 trial evaluated entinostat in combination with nivolumab in patients with previously treated unresectable or metastatic cholangioc…
-
CLINICAL_TRIALS trial_result · 2021-12-15Clinical Trial Update: Trial to Investigate Intensified Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating intensified neoadjuvant chemotherapy for locally advanced pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-12-10Clinical Trial Update: Phase 2 Study of S-1 in Advanced or Metastatic Pancreatic Cancer [Phase 2]
Phase 2 study of S-1 in locally advanced or metastatic pancreatic cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-12-03Clinical Trial Update: CD276-targeted Chimeric Antigen Receptor T Cells in Treatment With Advanced Pancreatic Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating CD276-targeted CAR-T cells in advanced pancreatic carcinoma.
-
CLINICAL_TRIALS trial_result · 2021-11-30Clinical Trial Update: A Study of Donafenib Plus S-1 in Treating Patients With Metastatic Pancreatic Cancer After Chemotherapy With Nab-paclitaxel Plus Gemcitabine Regimen [Phase 2]
Phase 2 clinical trial evaluating donafenib plus S-1 for metastatic pancreatic cancer after nab-paclitaxel plus gemcitabine failure.
-
CLINICAL_TRIALS trial_result · 2021-11-30Clinical Trial Update: Preoperative Exercise in Pancreatic Cancer [NA]
Clinical trial completed a preoperative exercise intervention in pancreatic cancer; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-10-29Clinical Trial Update: A Study of Mitoxantrone Hydrochloride Liposome Injection in Patients With Advanced Pancreatic Cancer [Phase 2]
Phase 2 trial of mitoxantrone hydrochloride liposome injection in advanced pancreatic cancer is ongoing with status unknown.
-
CLINICAL_TRIALS trial_result · 2021-10-22Clinical Trial Update: MFOLFIRINOX And Stereotactic Radiotherapy (SBRT) for Pancreatic Cancer With High Risk and Locally Advanced Disease [Phase 2]
Phase 2 trial update evaluating MFOLFIRINOX plus stereotactic radiotherapy (SBRT) in high-risk and locally advanced pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2021-10-19Clinical Trial Update: Study of Nivolumab, Cabiralizumab, and Stereotactic Body Radiotherapy (SBRT) for Locally Advanced Unresectable Pancreatic Cancer [Phase 2]
Phase 2 trial of nivolumab, cabiralizumab, and SBRT for locally advanced unresectable pancreatic cancer was terminated; results posted in 20…
-
CLINICAL_TRIALS trial_result · 2021-10-15Clinical Trial Update: Personal Resilience Empowerment Program Study [NA]
Clinical trial update for a study titled Personal Resilience Empowerment Program; status completed with results posted in 2021.